Ian N Bruce at The University of Manchester - Research Interests, Publications & Academic Profile

Ian N Bruce

The University of Manchester

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Pakistani students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

30%

Pharmacotherapy

30%

Systemic Lupus Erythematosus

80%

Rheumatology

40%

Anti-inflammatory Research

30%

Cohort Study

20%

Targeted Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Bioactive Lipid Mediators and Vascular Dysfunction in SLE

Open Date: 2021-03-01

Close Date: 2023-12-01

Grant: Open

EU IMI 3T Consortium

Open Date: 2019-09-01

Close Date: 2026-08-01

Grant: Close

NIHR Common Disease BioResource in Immune-Mediated Inflammatory Diseases

Open Date: 2019-01-01

Close Date: 2022-11-01

Grant: Close

NIHR Senior Investigator

Open Date: 2018-04-01

Close Date: 2021-03-01

Grant: Close

Immune-Mediated Inflammatory Disease Biobanks in the UK (IMIDBio-UK)

Open Date: 2017-09-01

Close Date: 2021-06-01

Articles11

A vasculitis mimic during pregnancy: autoimmune progesterone dermatitis

Article Link

Year:

2024

Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort

Article Link

Year:

2023

Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort

Article Link

Year:

2023

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

Article Link

Year:

2023

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

Article Link

Year:

2023

Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials

Article Link

Year:

2023

Health inequalities and systemic lupus erythematosus: a global challenge

Article Link

Year:

2023

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

Article Link

Year:

2023

Lupus spectrum ambiguity has long-term negative implications for patients

Article Link

Year:

2023

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance

Article Link

Year:

2022

Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis

Article Link

Year:

2022

Collaborators13

David A Isenberg

University College London

UNITED KINGDOM

Gwenda Simons

University of Birmingham

UNITED KINGDOM

Sarah Dyball

The University of Manchester

UNITED KINGDOM

John Reynolds

University of Birmingham

UNITED KINGDOM

Caroline Gordon

University of Birmingham

UNITED KINGDOM

Larissa Valor-Méndez

GERMANY

Jenny Humphreys

The University of Manchester

UNITED KINGDOM

Ronald van Vollenhoven

Professor and Chief

Amsterdam UMC

NETHERLANDS

Ian Giles

University College London

UNITED KINGDOM

Victoria P. Werth

UNITED STATES

Jorien Veldwijk

Erasmus University Rotterdam

NETHERLANDS

Hector Chinoy

The University of Manchester

UNITED KINGDOM

Eric Morand

MONASH UNIVERSITY

AUSTRALIA

How do Pakistani students reach out?

Meet Kite AI